News Posts List
Joanne battles stage 4 kidney cancer
03/18/2019
Four years ago, Joanne Romero, who lives in Texas, was diagnosed with stage 4 kidney cancer when she was 26 weeks pregnant. Despite her challenges, Joanne remains positive and hopes her story serves as an inspiration to others.
Dr. Marc-Oliver Grimm provided an overview of the many changes in the landscape for advanced renal cell carcinoma at the urogenital cancer treatment at a glance session
03/18/2019
In this article, Dr. Marc-Oliver Grimm provides an overview of the many changes in the landscape for advanced renal cell carcinoma at the urogenital cancer treatment at a glance session.
Antibiotics Before Checkpoint Inhibitors Tied to Worse Survival
03/11/2019
Use of broad-spectrum antibiotics 30 days before starting an immune checkpoint inhibitor was associated with a dramatic reduction in cancer patients' survival, a prospective study found.
Novel Agents and Drug Development Needs in Advanced Clear Cell Renal Cancer
03/07/2019
The treatment of metastatic clear cell renal cancer is changing rapidly, with the focus switching from vascular endothelial growth factor-targeted therapies to immune checkpoint inhibitors and novel combinations.
Toxicity, Clinical Outcomes of Varying Cabozantinib Dosage in Metastatic RCC
03/06/2019
While clinical outcomes may be comparable in patients with metastatic renal cell carcinoma (RCC) who are treated with full vs reduced dose of cabozantinib, reduced dose may not be associated with decreased adverse events.
Sarcomatoid Renal Cell Carcinoma: Population-Based Study of 879 Patients
03/05/2019
Sarcomatoid renal cell carcinoma (sRCC) constitutes a rare and aggressive subtype of renal cell carcinoma. This study investigates its clinicopathologic characteristics and outcomes at a national level.
A five-gene signature predicts overall survival of patients with papillary renal cell carcinoma
03/05/2019
This study aims to investigate the gene expression changes in papillary renal cell carcinoma(pRCC) and screen several genes and associated pathways of papillary renal cell carcinoma progression.